On the role of 5-HT(1B/1D) receptors in modulating transmission in a spinal reflex pathway in the decerebrated rabbit

British Journal of Pharmacology

Volumn 128, Issue 3, 1999, Pages 781-787

  Ogilvie, J ^a   Wigglesworth, M ^a,b   Appleby, L ^a   Kingston, T O W ^a   Clarke, R W ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

5 HT(1B) receptor; 5 HT(1D) receptor; 5 HT7 receptor; Nociception; Rabbit; Serotonin; Spinal cord; Withdrawal reflex

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3 [2 (DIMETHYLAMINO)ETHYL] 5 (1,2,4 TRIAZOL 1 YL)INDOLE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N [4 [5 [3 (2 AMINOETHYL) 1H INDOL 5 YL] 1,2,4 OXADIAZOL 3 YL]BENZYL]METHANESULFONAMIDE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; RITANSERIN; SEROTONIN 1B AGONIST; SEROTONIN 1B RECEPTOR; SEROTONIN 1D AGONIST; SEROTONIN 1D RECEPTOR; SEROTONIN 7 RECEPTOR; UNCLASSIFIED DRUG; SEROTONIN AGONIST; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DECEREBRATION; ELECTROSTIMULATION; FEMALE; GASTROCNEMIUS MUSCLE; HEART RATE; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOTONEURON; NEUROMODULATION; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RABBIT; REFLEX; SPINAL REFLEX; SURAL NERVE; ANIMAL; DRUG EFFECT; PHYSIOLOGY; SPINAL CORD;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; DECEREBRATE STATE; RABBITS; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTOR, SEROTONIN, 5-HT1D; RECEPTORS, SEROTONIN; REFLEX; SEROTONIN AGONISTS; SPINAL CORD;

EID: 0032589427     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702832     Document Type: Article

References (49)

1. 1B receptor subtypes in modulating spinal nociceptive transmission in mice. J. Pharmacol. Exp. Ther., 265, 378-385.
2. 7) positively linked to adenylate cyclase. J. Biol. Chem., 268, 23422-23426.
3. 1D receptor agonist. Br. J. Pharmacol., 110, 1196-1200.
4. 1D-like receptors mediate contraction of partially depolarised rabbit renal arteries. J. Pharmacol. Exp. Ther., 270, 650-655.
5. 1-like receptors revealed by precontraction of rabbit isolated mesenteric artery. Br. J. Pharmacol., 114, 309-314.
6. 1A-receptors. Br. J. Pharmacol., 122, 631-638.
7. 1B/1D receptors do not influence transmission in a withdrawal reflex pathway in the decerebrated and spinalized rabbit. J. Physiol., in press.
8. CUMBERBATCH, M.J., HILL, R.G. & HARGREAVES, R.J. (1997). Rizatriptan has central antinociceptive effects against durally evoked responses. Eur. J. Pharmacol., 328, 37-40.
9. 1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats. Eur. J. Pharmacol., 362, 43-46.
10. 1B/1D receptor agonist naratriptan on trigeminal versus spinal nociceptive responses. Cephalalgia, 18, 659-663.
11. 1 receptors in anaesthetized rabbits. Br. J. Pharmacol., 125, 409-417.
12. 1D receptors of 5-hydroxytryptamine-induced contractions of rabbit middle and posterior cerebral arteries. Br. J. Pharmacol., 112, 939-945.
13. 1B/1D receptor ligand, with functional 5-HT receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 355, 423-430.
14. 1B receptors in the modulation of a spinal nociceptive reflex. Brain Res., 536, 195-200.
15. 2A receptors in 5-HT-induced contraction of endothelium denuded rabbit epicardial coronary arteries. Br. J. Pharmacol., 122, 875-884.
16. 7 receptor antagonist. J. Med. Chem., 41, 655-657.
17. 1B receptor stimulation on nociceptive dorsal horn neurones in rats. Eur. J. Pharmacol., 335, 127-132.
18. 1B/D) receptor agonist zolmitriplan (311C90): Are brain stem sites therapeutic target in migraine? Pain, 67, 355-359.
19. 7 receptor in rat brain. Br. J. Pharmacol., 117, 657-666.
20. 1Dβ receptors. FEBS Lett., 377, 73-76.
21. 1A receptors: Behavioural and neurochemical pharmacology. Horwood: Chichester, pp 94-105.
22. 1B/1D) agonists in a model of trigeminovascular nociception in cat. Exp. Neurol., 150, 45-51.
23. HOSKIN, K.L., KAUBE, H. & GOADSBY, P.J. (1996). Sumatriptan can inhibit trigeminal afferents by an exclusively neural mechanism. Brain, 119, 1419-1428.
24. 1D binding sites in rabbit brain. Naunyn-Schmiedeberg's Arch. Pharmacol., 346, 249-254.
25. 1D in the rabbit and guinea-pig brain cortex. Naunyn-Schmiedeherg's Arch. Pharmacol., 343, 353-364.
26. 1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs. Cephalalgia, 17, 833-842.
27. 7) implicated in the regulation of mammalian circadian rhythms. Neuron, 11, 449-458.
28. 2 receptors in the rat spinal cord. Brain Res., 550, 15-23.
29. 1D) agonists and other agents in acute migraine. Neurologic Clinics, 15, 61-83.
30. MATSUMOTO, I., COMBS, M., BRANNAN, S. & JONES, D.J. (1990). Autoreceptor- and hetero-receptor-mediated regulation of monoamine release in spinal cord synaptosomes. Ann. N.Y. Acad. Sci., 604, 609-611.
31. 3H-5-Hydroxytryptamine release. J. Pharmacol. Exp. Ther., 260, 614-626.
32. 1B/1D agonist CGS-12066B attenuates clasp knife reflex in the cat. J. Neurophysiol., 74, 453-456.
33. 1B receptors in spinal nociceptive transmission and in the modulation of NMDA induced behaviour. Neuroreport, 3, 1061-1064.
34. 1A-receptors in rabbit spinal cord in vivo. Br. J. Pharmacol., 123, 1138-1142.
35. OGILVIE, J., SIMPSON, D.A.A. & CLARKE, R.W. (1999). Tonic adrenergic and serotonergic inhibition of a withdrawal reflex in rabbits subjected to different levels of surgical preparation. Neuroscience, 89, 1247-1258.
36. PIERCE, P.A., XIE, G.X., LEVINE, J.D. & PEROUTKA. S.J. (1996). 5-hydroxytryptamine receptor subtype messenger RNAs in rat peripheral sensory and sympathetic ganglia: A polymerase chain reaction study. Neuroscience. 70, 553-559.
37. PIERCE, P.A., XIE, G.X., MEUSER, T. & PEROUTKA, S.J. (1997). 5-hydroxytryptamine receptor subtype messenger rnas in human dorsal root ganglia: a polymerase chain reaction study. Neuroscience, 81, 813-819.
38. 1D receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 356, 312-320.
39. 7) activating cAMP formation. Proc. Natl. Acad. Sci. U.S.A., 90, 8547-8551.
40. 1B receptor antagonist with negative intrinsic activity. Br. J. Pharmacol., 125, 202-208.
41. 1D receptor antagonist. Behav. Brain Res., 73, 157-161.
42. 1D receptors. Bioorg. Med. Chem. Lett., 6, 1825-1830.
43. 1Cγ2 binding sites in the rat spinal cord. Neuroscience, 55, 235-252.
44. 1D receptor agonists in the rabbit isolated saphenous vein. Br. J. Pharmacol., 119, 35-42.
45. VAN WIJNGAARDEN, I., TULP, M.T.H. & SOUDIJN, W. (1990). The concept of selectivity in 5-HT receptor research. Eur. J. Pharmacol., 188, 301-312.
46. 35S-GTPγS binding: correlation with inhibition of guinea pig dural plasma protein extravasation. Eur. J. Pharmacol., 352, 117-124.
47. 1Dβ receptors. Eur. J. Pharmacol., 314, 365-372.
48. 1D receptors. J. Phyniol., 504P, 104P.
49. 1B receptors. Br. J. Pharmacol., 120, 153-159.